Stay up to date on recent advances in oncology nursing and patient care.
Imlunestrant vs Elacestrant: MOA and Clinical Trial Differences
Amber Pierce Underscores the Importance of 2-Step Verification With Relatlimab/Nivolumab
Ivonescimab/Chemo Ups PFS After Third-Generation TKI in EGFR+ NSCLC
Krista Rubin Breaks Down Best Practices With Tebentafusp for Uveal Melanoma
AE Education Aids Breast Cancer Decisions, Says Survivorship Expert
NCCN Guidelines Update Includes HEPZATO KIT for Uveal Melanoma
The Reality of VTE: How to Best Address in Cancer Care
AI Decision Support Tools Serve as Copilots in Cancer Care
Toxicity Monitoring, Management Crucial for Tarlatamab in ES-SCLC
Cancer Drug Repository Network Yields $18M in Patient Savings
